Sephoris Pharmaceuticals LLC
Israel
- Country
- Israel
- Ownership
- Private
- Employees
- -
- Market Cap
- -
Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Clinical Trial of the Safety and Efficacy of SP160412 in the Temporary Relief of Mild to Moderate Sunburn
Phase 2
Terminated
- Conditions
- Sunburn
- Interventions
- Drug: 2 capsules Ibuprofen and 1 placebo
- First Posted Date
- 2017-11-06
- Last Posted Date
- 2019-09-27
- Lead Sponsor
- Sephoris Pharmaceuticals LLC
- Target Recruit Count
- 80
- Registration Number
- NCT03332524
- Locations
- 🇲🇺
CIDP, Phoenix, Mauritius
News
No news found